home / stock / sva:cc / sva:cc news

SVA:CC News and Press, Sernova Corp. From 04/14/23

Stock Information
Company Name: Sernova Corp.
Stock Symbol: SVA:CC
Market: TSXVC
Website: sernova.com
Menu
SVA:CC SVA:CC Quote SVA:CC Short SVA:CC News SVA:CC Articles SVA:CC Message Board
Get SVA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
SVA:CC - UPDATE -- Institutional Shareholder Services Inc. Recommends Sernova's Shareholders Vote FOR all Management Nominees on Management's White Proxy

ISS, an independent, third-party proxy advisory firm, recommends Sernova’s shareholders vote FOR all management’s director nominees using ONLY management’s WHITE proxy. ISS notes the dissidents failed to present a detailed explanation of their case and there ...
SVA:CC - Institutional Shareholder Services Inc. Recommends Senova's Shareholders Vote FOR all Management Nominees on Management's White Proxy

ISS, an independent, third-party proxy advisory firm, recommends Sernova’s shareholders vote FOR all management’s director nominees using ONLY management’s WHITE proxy. ISS notes the dissidents failed to present a detailed explanation of their case and there ...

SVA:CC - Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med

LONDON, Ontario, April 10, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced that President and Chief Executive Officer, Dr. Philip Toleikis, will present at the upcoming annual Cell & Gene...

SVA:CC - Sernova Responds to Dissident Shareholders' Misleading Statements and Provides Corporate Updates

The dissident director nominees declined to follow proper protocol to participate in Sernova’s board renewal process and instead are imposing themselves on the Company through a costly and disruptive proxy battle Management and the Board have placed Sernova in a position to bring v...
SVA:CC - Concerned Shareholders of Sernova Corp. Nominate Two Highly Qualified Directors to the Board

Concerned Shareholders of Sernova Corp. Nominate Two Highly Qualified Directors to the Board Canada NewsWire Concerned shareholder group has issued an information circular and letter to shareholders outlining reasons for change TORONTO , April 3, 2023 /CN...

SVA:CC - Sernova Announces Abstract on First Cohort of its Phase 1/2 Study Involving Islet Allotransplantation into Pre-vascularized Cell Pouch(TM) Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions 2023

LONDON, Ontario, March 22, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, is pleased to announce that an abstract has been selected for an oral podium presentation at the upcoming American Diabetes Associat...

SVA:CC - Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch(TM) Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit

LONDON, Ontario, March 14, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, announced today that an abstract has been selected for an oral presentation at the 4 th International Pancreas and Islet Transpl...
SVA:CC - Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes

Third patient now implanted with higher capacity, 10-chamber Cell Pouch Company anticipates first interim data from second cohort in Q4 2023 LONDON, Ontario, March 08, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and le...

SVA:CC - Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences

LONDON, Ontario, March 02, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it will be participating in the upcoming 35th Annual Roth Conference being held March 12-14, 2023 and the Oppenheime...

SVA:CC - Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference

Sernova (TSX: SVA) is a clinical-stage biotechnology company developing therapeutic cell technologies with a goal to deliver a 'functional cure' for chronic diseases, including insulin-dependent diabetes, thyroid disease and hemophilia A. Sernova has developed the Cell Pouch System(TM), an impla...
Previous 10 Next 10